Published in J Am Heart Assoc on June 22, 2012
Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics (2015) 1.66
SWI/SNF chromatin remodeling enzymes are associated with cardiac hypertrophy in a genetic rat model of hypertension. J Cell Physiol (2013) 0.83
Analysis of metabolites in plasma reveals distinct metabolic features between Dahl salt-sensitive rats and consomic SS.13(BN) rats. Biochem Biophys Res Commun (2014) 0.80
Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure. Kidney Int (2016) 0.75
High-resolution mapping of a novel rat blood pressure locus on chromosome 9 to a region containing the Spp2 gene and colocalization of a QTL for bone mass. Physiol Genomics (2016) 0.75
Renal denervation to treat cardiac fibrosis? J Am Heart Assoc (2014) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A (2012) 11.23
Molecular mechanisms of human hypertension. Cell (2001) 11.17
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol (2011) 8.45
Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20
Salt intakes around the world: implications for public health. Int J Epidemiol (2009) 5.05
Blood pressure control--special role of the kidneys and body fluids. Science (1991) 4.48
A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet (2009) 4.28
Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10
The ADAMTS metalloproteinases. Biochem J (2005) 3.95
A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature (1992) 3.40
Isozymes of the Na+/K+-ATPase. Biochim Biophys Acta (1989) 2.97
Haplotypic analysis of Wellcome Trust Case Control Consortium data. Hum Genet (2008) 2.92
Genetic analysis of inherited hypertension in the rat. Physiol Rev (2000) 2.78
The genetic dissection of essential hypertension. Nat Rev Genet (2006) 2.77
Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med (1962) 2.75
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension (2006) 2.64
Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A (1991) 2.20
Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol (2005) 2.18
Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab (2012) 2.18
Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev (2009) 2.17
The epidemiology of salt and hypertension. Clin Auton Res (2002) 2.04
Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep (2010) 2.03
Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension (2001) 1.99
Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature (1962) 1.93
Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell (2005) 1.92
Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation (1999) 1.81
Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem (2001) 1.80
New target regions for human hypertension via comparative genomics. Genome Res (2000) 1.75
Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase. J Biol Chem (2004) 1.71
Substitution mapping of a blood pressure quantitative trait locus to a 2.73 Mb region on rat chromosome 1. J Hypertens (2003) 1.69
Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts. Cardiovasc Res (2006) 1.67
Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem (2000) 1.63
Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem (2000) 1.60
Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics (2007) 1.57
An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet (1999) 1.56
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet (1992) 1.55
Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem (1999) 1.52
Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem (2002) 1.51
Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol (2010) 1.51
Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet (2008) 1.45
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension (2006) 1.42
Genetic determinants of QT interval variation and sudden cardiac death. Curr Opin Genet Dev (2007) 1.38
Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am J Physiol Renal Physiol (2008) 1.37
Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int (2004) 1.37
Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics (2003) 1.37
Genetic determinants of human hypertension. Proc Natl Acad Sci U S A (1995) 1.37
Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell (2005) 1.36
Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol (2008) 1.35
Two major QTLs and several others relate to factors of metabolic syndrome in the family blood pressure program. Hypertension (2005) 1.32
Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol (2007) 1.31
2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radic Res (2010) 1.31
Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension. Circulation (2002) 1.30
Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension (2012) 1.28
Genome scan and congenic strains for blood pressure QTL using Dahl salt-sensitive rats. Genome Res (1998) 1.28
Gene targeting in the rat: advances and opportunities. Trends Genet (2010) 1.25
The INTERSALT study: results for 24 hour sodium and potassium, by age and sex. INTERSALT Co-operative Research Group. J Hum Hypertens (1989) 1.25
Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats. Am J Physiol Renal Physiol (2007) 1.24
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol (2009) 1.23
Positional identification of variants of Adamts16 linked to inherited hypertension. Hum Mol Genet (2009) 1.21
Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats. Physiol Genomics (2008) 1.21
Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int (2005) 1.19
Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats. Circulation (2000) 1.17
Linkage map and congenic strains to localize blood pressure QTL on rat chromosome 10. Mamm Genome (1997) 1.17
Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array. Physiol Genomics (2005) 1.14
Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int (2005) 1.14
Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics (2003) 1.14
A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem (2005) 1.13
Role of dietary salt in hypertension. Life Sci (2006) 1.12
Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Am J Hypertens (2012) 1.11
A genome-wide association study of hypertension-related phenotypes in a Japanese population. Circ J (2010) 1.10
Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial K(ATP) channels. Mol Cell Biochem (2003) 1.10
Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study. Physiol Genomics (2002) 1.10
Creation and characterization of a renin knockout rat. Hypertension (2011) 1.09
Defining the blood pressure QTL on chromosome 7 in Dahl rats by a 177-kb congenic segment containing Cyp11b1. Mamm Genome (2003) 1.09
Genetic basis of polygenic hypertension. Hum Mol Genet (2007) 1.09
Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J Hypertens (2005) 1.06
Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics (2009) 1.06
From JNC I to JNC 7--what have we learned? Prog Cardiovasc Dis (2006) 1.05
A review of the ADAMTS family, pharmaceutical targets of the future. Curr Pharm Des (2009) 1.05
Genome-wide association studies will unlock the genetic basis of hypertension.: con side of the argument. Hypertension (2010) 1.05
Epigenetics and hypertension. Curr Hypertens Rep (2011) 1.04
The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol (2009) 1.02
Epigenetics in cardiovascular disease. Curr Opin Cardiol (2011) 1.02
JNC 7: brief summary and critique. Clin Exp Hypertens (2005) 1.01
Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad. Eur J Pharmacol (1993) 1.01
Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase. J Pharmacol Exp Ther (1981) 1.00
Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension. Hypertension (2011) 0.99
Genome-wide scan for pulse pressure in the National Heart, Lung and Blood Institute's Framingham Heart Study. Hypertension (2004) 0.99
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension (2009) 0.99
Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex. Am J Physiol Cell Physiol (2007) 0.99
Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int (2003) 0.98
Impairment of Na/K-ATPase signaling in renal proximal tubule contributes to Dahl salt-sensitive hypertension. J Biol Chem (2011) 0.98
Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. Eur J Pharmacol (1995) 0.98
Salt, Na+,K+-ATPase and hypertension. Life Sci (2009) 0.97
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension (2006) 2.64
Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol (2005) 2.18
Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis (2003) 2.18
Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev (2009) 2.17
Embolic protection and platelet inhibition during renal artery stenting. Circulation (2008) 1.52
Effects of cardiotonic steroids on dermal collagen synthesis and wound healing. J Appl Physiol (1985) (2008) 1.45
Complete versus partial distal embolic protection during renal artery stenting. Catheter Cardiovasc Interv (2009) 1.44
Hyponatremia: clinical diagnosis and management. Am J Med (2007) 1.43
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension (2006) 1.42
Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat. Kidney Int (2002) 1.41
Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int (2004) 1.37
Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol (2008) 1.35
Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol (2007) 1.31
Impact of preadmission variables on USMLE step 1 and step 2 performance. Adv Health Sci Educ Theory Pract (2007) 1.25
Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol (2009) 1.23
Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int (2005) 1.19
Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int (2005) 1.14
Principles of management of severe hyponatremia. J Am Heart Assoc (2013) 1.12
Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Am J Hypertens (2012) 1.11
Endocytosis and signal transduction: basic science update. Biol Res Nurs (2003) 1.10
Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial K(ATP) channels. Mol Cell Biochem (2003) 1.10
Predictors of embolization during protected renal artery angioplasty and stenting: Role of antiplatelet therapy. Catheter Cardiovasc Interv (2010) 1.09
NaKtide, a Na/K-ATPase-derived peptide Src inhibitor, antagonizes ouabain-activated signal transduction in cultured cells. J Biol Chem (2009) 1.04
Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade. Stem Cell Res Ther (2013) 1.04
Determinants of renal function in patients with renal artery stenosis. Vasc Med (2011) 1.03
Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol (2003) 1.03
The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol (2009) 1.02
Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int (2002) 1.00
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension (2009) 0.99
Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex. Am J Physiol Cell Physiol (2007) 0.99
CD36 and Na/K-ATPase-α1 form a proinflammatory signaling loop in kidney. Hypertension (2012) 0.99
Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int (2003) 0.98
Impairment of Na/K-ATPase signaling in renal proximal tubule contributes to Dahl salt-sensitive hypertension. J Biol Chem (2011) 0.98
Na/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells. J Biol Chem (2011) 0.97
Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation. Am J Physiol Heart Circ Physiol (2006) 0.96
Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis. J Biol Chem (2012) 0.95
Endogenous cardiotonic steroids in chronic renal failure. Nephrol Dial Transplant (2011) 0.95
Regulation of sodium pump endocytosis by cardiotonic steroids: Molecular mechanisms and physiological implications. Pathophysiology (2007) 0.95
Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochim Biophys Acta (2010) 0.94
In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries. J Hypertens (2011) 0.92
Ouabain-stimulated trafficking regulation of the Na/K-ATPase and NHE3 in renal proximal tubule cells. Mol Cell Biochem (2012) 0.91
Reactive Oxygen Species Modulation of Na/K-ATPase Regulates Fibrosis and Renal Proximal Tubular Sodium Handling. Int J Nephrol (2012) 0.90
Involvement of reactive oxygen species in a feed-forward mechanism of Na/K-ATPase-mediated signaling transduction. J Biol Chem (2013) 0.89
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia. PLoS One (2013) 0.89
"Pseudo-sickle" cell anemia. Am J Med Sci (2009) 0.84
Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease. Am J Hypertens (2013) 0.84
Rapid effects of aldosterone and spironolactone in the isolated working rat heart. Hypertension (2002) 0.84
Down-regulation of the transcription factor snail in the placentas of patients with preeclampsia and in a rat model of preeclampsia. Reprod Biol Endocrinol (2012) 0.83
Mechanisms for aldosterone and spironolactone-induced positive inotropic actions in the rat heart. Hypertension (2004) 0.83
Stem cell transplantation increases antioxidant effects in diabetic mice. Int J Biol Sci (2012) 0.82
Mitochondrial impairment in the five-sixth nephrectomy model of chronic renal failure: proteomic approach. BMC Nephrol (2013) 0.81
Erythropoietin resistance in the treatment of the anemia of chronic renal failure. Semin Dial (2006) 0.81
Uremic cardiomyopathy: role of circulating digitalis like substances. Front Biosci (2005) 0.81
Renal ischemia regulates marinobufagenin release in humans. Hypertension (2010) 0.80
Ouabain and insulin induce sodium pump endocytosis in renal epithelium. Hypertension (2012) 0.80
Plasma expansion by polyethylene-glycol-modified albumin. Clin Sci (Lond) (2004) 0.80
Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization. Clin J Am Soc Nephrol (2011) 0.79
Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study. J Am Soc Nephrol (2006) 0.79
Identification of hydroxyxanthones as Na/K-ATPase ligands. Mol Pharmacol (2010) 0.78
Neural network analysis to predict mortality in end-stage renal disease: application to United States Renal Data System. Nephron Clin Pract (2010) 0.78
Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia. Int Urol Nephrol (2009) 0.77
Effect of CD40 and sCD40L on renal function and survival in patients with renal artery stenosis. Hypertension (2013) 0.77
Use of multiple fluorophores for evaluating microvascular permeability in control rats and rats with sepsis. Clin Sci (Lond) (2008) 0.76
Renal denervation to treat cardiac fibrosis? J Am Heart Assoc (2014) 0.75
How safe is unilateral nephrectomy? Hypertension (2012) 0.75
Signaling through the Na/K-ATPase: implications for cardiac fibrosis. Am J Physiol Heart Circ Physiol (2010) 0.75
Compliance with antihypertensive therapy after renal artery stenting. Biol Res Nurs (2003) 0.75
Potassium depletion and cardiac hypertrophy: how does it work? Hypertension (2005) 0.75
Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors? Am J Med Sci (2014) 0.75
Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy. Sci Rep (2017) 0.75
Arthur Guyton, sodium, and hypertension. Biol Res Nurs (2003) 0.75
Quality of life improves after renal artery stenting. Biol Res Nurs (2006) 0.75